Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Cited In for PubMed (Select 8070403)


Elevated expression of NEDD9 is associated with metastatic activity in gastric cancer.

Zhang SS, Wu LH, Liu Q, Chen KS, Zhang XF.

Onco Targets Ther. 2015 Mar 10;8:633-40. doi: 10.2147/OTT.S77904. eCollection 2015.


Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity.

Ng KY, Yin T, Machida K, Wu YI, Mayer BJ.

Oncogene. 2015 May 14;34(20):2650-9. doi: 10.1038/onc.2014.210. Epub 2014 Jul 21.


p53-mediated activation of the mitochondrial protease HtrA2/Omi prevents cell invasion.

Yamauchi S, Hou YY, Guo AK, Hirata H, Nakajima W, Yip AK, Yu CH, Harada I, Chiam KH, Sawada Y, Tanaka N, Kawauchi K.

J Cell Biol. 2014 Mar 31;204(7):1191-207. doi: 10.1083/jcb.201309107. Epub 2014 Mar 24.


Oligodendroglial p130Cas is a target of Fyn kinase involved in process formation, cell migration and survival.

Gonsior C, Binamé F, Frühbeis C, Bauer NM, Hoch-Kraft P, Luhmann HJ, Trotter J, White R.

PLoS One. 2014 Feb 21;9(2):e89423. doi: 10.1371/journal.pone.0089423. eCollection 2014.


Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Wallez Y, Riedl SJ, Pasquale EB.

J Biol Chem. 2014 Apr 11;289(15):10431-44. doi: 10.1074/jbc.M113.541839. Epub 2014 Feb 28.


p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells.

Cunningham-Edmondson AC, Hanks SK.

Breast Cancer (Dove Med Press). 2009 Dec 7;1:39-52. eCollection 2009.


Causal inference of gene regulation with subnetwork assembly from genetical genomics data.

Peng CH, Jiang YZ, Tai AS, Liu CB, Peng SC, Liao CT, Yen TC, Hsieh WP.

Nucleic Acids Res. 2014 Mar;42(5):2803-19. doi: 10.1093/nar/gkt1277. Epub 2013 Dec 9.


Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma.

Mercurio S, Padovani L, Colin C, Carré M, Tchoghandjian A, Scavarda D, Lambert S, Baeza-Kallee N, Fernandez C, Chappé C, André N, Figarella-Branger D.

Acta Neuropathol Commun. 2013 May 20;1:17. doi: 10.1186/2051-5960-1-17.


The emerin-binding transcription factor Lmo7 is regulated by association with p130Cas at focal adhesions.

Wozniak MA, Baker BM, Chen CS, Wilson KL.

PeerJ. 2013 Aug 20;1:e134. doi: 10.7717/peerj.134. eCollection 2013.


Cysteine-rich protein 2 alters p130Cas localization and inhibits vascular smooth muscle cell migration.

Chen CH, Ho YC, Ho HH, Chang IC, Kirsch KH, Chuang YJ, Layne MD, Yet SF.

Cardiovasc Res. 2013 Dec 1;100(3):461-71. doi: 10.1093/cvr/cvt207. Epub 2013 Aug 23.


The role of mechanical force and ROS in integrin-dependent signals.

Zeller KS, Riaz A, Sarve H, Li J, Tengholm A, Johansson S.

PLoS One. 2013 May 30;8(5):e64897. doi: 10.1371/journal.pone.0064897. Print 2013.


Dynamic regulation of the structure and functions of integrin adhesions.

Wolfenson H, Lavelin I, Geiger B.

Dev Cell. 2013 Mar 11;24(5):447-58. doi: 10.1016/j.devcel.2013.02.012. Review.


Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.

Zheng Y, Tyner AL.

Eur J Clin Invest. 2013 Apr;43(4):397-404. doi: 10.1111/eci.12050. Epub 2013 Feb 10. Review.


Acquisition of the metastatic phenotype is accompanied by H2O2-dependent activation of the p130Cas signaling complex.

Hempel N, Bartling TR, Mian B, Melendez JA.

Mol Cancer Res. 2013 Mar;11(3):303-12. doi: 10.1158/1541-7786.MCR-12-0478. Epub 2013 Jan 23.


Mechano-sensing by actin filaments and focal adhesion proteins.

Hayakawa K, Tatsumi H, Sokabe M.

Commun Integr Biol. 2012 Nov 1;5(6):572-7. doi: 10.4161/cib.21891.


SRC points the way to biomarkers and chemotherapeutic targets.

Krishnan H, Miller WT, Goldberg GS.

Genes Cancer. 2012 May;3(5-6):426-35. doi: 10.1177/1947601912458583.


Src, p130Cas, and Mechanotransduction in Cancer Cells.

Matsui H, Harada I, Sawada Y.

Genes Cancer. 2012 May;3(5-6):394-401. doi: 10.1177/1947601912461443.


Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton.

Guerrero MS, Parsons JT, Bouton AH.

Genes Cancer. 2012 May;3(5-6):371-81. doi: 10.1177/1947601912458585.


Models of crk adaptor proteins in cancer.

Bell ES, Park M.

Genes Cancer. 2012 May;3(5-6):341-52. doi: 10.1177/1947601912459951.


Protein tyrosine phosphatase α phosphotyrosyl-789 binds BCAR3 to position Cas for activation at integrin-mediated focal adhesions.

Sun G, Cheng SY, Chen M, Lim CJ, Pallen CJ.

Mol Cell Biol. 2012 Sep;32(18):3776-89. doi: 10.1128/MCB.00214-12. Epub 2012 Jul 16.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk